Omzo vs Vaylen: Compare compounded semaglutide plans
Quick verdict: Omzo vs Vaylen
The core difference in an Omzo vs Vaylen choice is how you pay and what formats you need. Omzo emphasizes clinician-guided, personalized compounded semaglutide starting at $179 and clinician review before payment. Vaylen offers lower prepaid monthly rates from $83.25/mo on a 12-month plan and includes injectable and oral semaglutide, but you pay before clinician review with a full refund if declined. This means Omzo favors clinician-first guidance while Vaylen favors lower prepaid pricing and multiple formats.
Explore Omzo clinician-guided plans
How the two compare at a glance
| Criteria | Omzo | Vaylen |
|---|---|---|
| Starting price | Semaglutide starting at $179; tirzepatide starting at $279 | Semaglutide from $83.25/mo on 12-month plan or $224/mo month to month |
| Medication formats | Compounded semaglutide and tirzepatide, one weekly injection | Compounded semaglutide injectable, oral semaglutide tablet, and tirzepatide |
| Payment and timing | Clinician-guided plans; platform connects you with licensed U.S. providers who determine eligibility before prescription | Prepay 12 months before clinician review; full refund if clinician declines |
| Compounded status | Compounded medications prepared by state-licensed sterile compounding pharmacy; not FDA-approved | Compounded medications not FDA-approved finished products |
| Shipping and turnaround | Fast, discreet delivery; FSA and HSA eligible indicated | Free discreet shipping in 1 to 3 business days; clinician review within 24 hours |
| Best for | People who confirm eligibility, medication, total cost, renewal terms and state availability before enrollment | Decisive buyers who accept prepaid compounded GLP-1 and want lower effective monthly rates |
Payment model and price structure
Omzo lists semaglutide starting at $179 and tirzepatide starting at $279 and connects you to licensed clinicians who determine eligibility and prescription decisions. Vaylen publishes an annualized 12-month pricing model with semaglutide from $83.25/mo billed upfront or $224/mo on a month to month plan. Vaylen requires prepayment for the 12-month pricing, with a stated full refund if a clinician declines to prescribe.
See Vaylen prepaid pricing and formats
Medication formats and clinician process
Both platforms offer compounded GLP-1 medications that are not FDA-approved. Omzo focuses on compounded semaglutide and tirzepatide delivered as weekly injections and highlights clinician-guided plans reviewed by licensed U.S. providers before prescribing. Vaylen offers injectable semaglutide, tirzepatide, and a daily oral semaglutide tablet on one platform and states a clinician reviews your submitted health form within 24 hours after you pay. Vaylen notes the oral tablet costs about $16/mo more on the prepaid plan than the injectable semaglutide on the same plan.
Regulatory and safety disclosures
Both Omzo and Vaylen disclose that compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality. Omzo specifies its compounded medications are prepared and shipped by a state-licensed sterile compounding pharmacy and are not FDA-approved finished products. Vaylen likewise states compounds are not FDA-approved finished products and have not been evaluated by the FDA.
Review Omzo’s prescribing and compounding details
Shipping, refunds, and service features
Vaylen advertises free discreet shipping in 1 to 3 business days and a published full refund if the clinician declines to prescribe, with telehealth consultations included and licensed clinicians in all 50 states. Omzo highlights fast, discreet delivery and FSA and HSA eligibility but emphasizes clinicians in third party networks make final prescribing decisions; Omzo is not a medical practice, and eligibility is determined by the prescribing provider.
Distinctive differences summarized
- Payment timing: Omzo routes patients to clinician review before prescription decisions; Vaylen requires prepayment for its lowest annualized rates but offers a full refund if declined.
- Price and billing: Omzo lists per-treatment starting prices like $179 for semaglutide; Vaylen advertises lower prepaid monthly rates such as $83.25/mo on a 12-month plan.
- Formats available: Vaylen includes a needle-free oral semaglutide tablet; Omzo emphasizes weekly injectable semaglutide and tirzepatide options.
- Regulatory note: Both clearly state compounded medications are not FDA-approved.
Compare Omzo treatment options
Conclusion: choosing between Omzo vs Vaylen
Choose Omzo if you want clinician-first review and personalized clinician-guided plans with compounded semaglutide and tirzepatide where providers determine eligibility before prescriptions. Choose Vaylen if you are comfortable prepaying a 12-month plan to access lower monthly rates, want injectable plus oral semaglutide formats, and value a published refund if the clinician declines.
Both providers disclose that compounded medications are not FDA-approved. Confirm eligibility, medication options, renewal terms, shipping, and state availability directly with each provider before enrolling.